Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to IgA Nephropathy
Related studies linked through entity extraction aliases.
Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
- Status
- WITHDRAWN
- Phase
- PHASE3
Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
- Status
- TERMINATED
- Phase
- PHASE3
Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
- Status
- COMPLETED
- Phase
- NA